Immix Biopharma, Inc. reports

Company location: Los Angeles, CA
Fiscal year end: 31 December

Immix Biopharma, Inc. has filed 239 SEC EDGAR filings since 20 Jul 2021

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 51-75 of 239 matching filings.

Per page

25

Current page

3

4

4 filing

Filing date: 17 Sep 2025
Reporting date: 17 Sep 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 17 Sep 2025
Reporting date: 16 Sep 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

3

3 filing

Filing date: 17 Sep 2025
Reporting date: 08 Sep 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-41159

8-K

Filing date: 08 Sep 2025
Reporting date: 05 Sep 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-41159

10-Q

Filing date: 08 Aug 2025
Reporting date: 30 Jun 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-41159

8-K

Filing date: 23 Jun 2025
Reporting date: 20 Jun 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

4 filing

Filing date: 23 Jun 2025
Reporting date: 20 Jun 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 23 Jun 2025
Reporting date: 20 Jun 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 23 Jun 2025
Reporting date: 20 Jun 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 23 Jun 2025
Reporting date: 20 Jun 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 23 Jun 2025
Reporting date: 20 Jun 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 23 Jun 2025
Reporting date: 20 Jun 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 23 Jun 2025
Reporting date: 20 Jun 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 23 Jun 2025
Reporting date: 20 Jun 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 20 Jun 2025
Reporting date: 18 Jun 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 20 Jun 2025
Reporting date: 18 Jun 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

424B5 File 333-269100

424B5

Filing date: 03 Jun 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-41159

8-K

Filing date: 03 Jun 2025
Reporting date: 03 Jun 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

ARS File 001-41159

ARS

Filing date: 19 May 2025
Reporting date: 31 Dec 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q/A File 001-41159

10-Q/A

Filing date: 19 May 2025
Reporting date: 31 Mar 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

DEFA14A File 001-41159

DEFA14A

Filing date: 19 May 2025
Reporting date: Not listed
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K/A File 001-41159

10-K/A

Filing date: 19 May 2025
Reporting date: 31 Dec 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-41159

10-Q

Filing date: 08 May 2025
Reporting date: 31 Mar 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

DEFA14A File 001-41159

DEFA14A

Filing date: 05 May 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

DEF 14A File 001-41159

DEF 14A filing

Filing date: 30 Apr 2025
Reporting date: 29 Apr 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .